title: Cardiac implantable devices: surveillance of surgical site infections and assessment of professional practices.
abstract: BACKGROUND
  A programme for quality assurance and prevention of infection risk during implantation of cardiac medical devices (pacemakers and defibrillators) was set up in our hospital.
  
  
  OBJECTIVE
  We sought to assess surgical site infection rate and compliance with infection-control practices (principally antibiotic prophylaxis).
  
  
  METHODS
  Surgical site infections associated with implanted medical devices were monitored in patients during a 6-month period and a 1-year follow-up. Professional practices concerning the use of prophylactic antibiotics in surgery were assessed.
  
  
  RESULTS
  The surgical site infection rate was 2.3%. Overall compliance was 45% for the use of antibiotic prophylaxis.
  
  
  CONCLUSIONS
  Optimal compliance with antibiotic prophylaxis was not reached in the present series, which demonstrated a surgical site infection rate of 2.3%. More effort must be made to achieve full compliance with preventive measures in the implantation of medical devices.
authors.affiliation: Unité d'épidémiologie et hygiène hospitalière, service d'épidémiologie, hôpital Rangueil, Toulouse, France. uohrg.erv@chu-toulouse.fr
authors.forename: Maguy
authors.initials: M
authors.lastname: Metais
authors.forename: Aurélien
authors.initials: A
authors.lastname: Hebrard
authors.forename: Alexandre
authors.initials: A
authors.lastname: Duparc
authors.forename: Pierre
authors.initials: P
authors.lastname: Mondoly
authors.forename: Marc
authors.initials: M
authors.lastname: Delay
authors.forename: Benoît
authors.initials: B
authors.lastname: Lepage
authors.forename: Sandra
authors.initials: S
authors.lastname: Malavaud
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000592:standards*; D002983:Clinical Competence / Q000592:standards; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D005260:Female; D005602:France; D019983:Guideline Adherence; D006235:Hand Disinfection / Q000592:standards; D006801:Humans; D017053:Infection Control / Q000592:standards*; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care / Q000592:standards; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards; D011364:Professional Practice / Q000592:standards*; D015397:Program Evaluation; D011446:Prospective Studies; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000517:prevention & control*; D011785:Quality Assurance, Health Care / Q000592:standards*; D018570:Risk Assessment; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000891:Anti-Infective Agents, Local